Wholesale of pharmaceutical and medical goods
SANA PHARMA MEDICAL AS
Revenue 2024
NOK 67.2m
Operating profit
NOK −6.8m
Equity
NOK −5.9m
Incorporated
1994
Employees
9
Share capital
NOK 270,000
Varemerker (19)
| Name | Application no. | Reg. no. | Status | Status date | Expires |
|---|---|---|---|---|---|
| Eir Pharma | 202607414 | – | Under behandling | 2026-06-16 | – |
| Lifa Pharma | 202607415 | – | Under behandling | 2026-06-16 | – |
| SENIKOL | 202301072 | 326486 | Registrert | 2023-04-25 | 2033-01-25 |
| Stexxa | 202203833 | 322356 | Registrert | 2022-06-13 | 2032-03-15 |
| Nopxan | 202200630 | 320131 | Registrert | 2022-01-28 | 2032-01-13 |
| Saddazyl | 202200662 | 320038 | Registrert | 2022-01-24 | 2032-01-17 |
| Wrexal | 202200700 | 320037 | Registrert | 2022-01-24 | 2032-01-18 |
| GIDUXA | 202116591 | 319211 | Registrert | 2021-12-08 | 2031-11-30 |
| Dxvira | 202107602 | 316144 | Registrert | 2021-06-17 | 2031-06-10 |
| Sedix Forte | 202105986 | 315537 | Registrert | 2021-05-12 | 2031-05-05 |
| SOLVENIX | 201915315 | 312590 | Registrert | 2020-11-18 | 2029-11-13 |
| ENTOLEX | 202004568 | 309389 | Registrert | 2020-04-16 | 2030-04-07 |
| DENAFEN | 202004571 | 309390 | Registrert | 2020-04-16 | 2030-04-07 |
| DURANOCT | 202004604 | 309322 | Registrert | 2020-04-14 | 2030-04-08 |
| LUNIXEN | 201810076 | 301936 | Registrert | 2019-01-16 | 2028-08-01 |
| SEDIX | 201501654 | 283795 | Registrert | 2015-10-08 | 2035-02-10 |
| SEDIZIN | 201405156 | 277293 | Registrert | 2014-08-20 | 2034-04-30 |
| SanaPharma | 201012797 | 260265 | Registrert | 2011-06-06 | 2030-12-06 |
| SANTOSOLVE | 200113405 | 215261 | Registrert | 2002-08-01 | 2032-08-01 |
Source: Patentstyret
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.